Macquarie Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.77M | Sell |
14,170
-1,517
| -10% | -$295K | 0.02% | 470 |
|
|
2025
Q4 | $2.72M | Sell |
15,687
-255,634
| -94% | -$46.5M | 0.01% | 524 |
|
|
2025
Q3 | $51.7M | Sell |
271,321
-20,565
| -7% | -$3.65M | 0.06% | 412 |
|
|
2025
Q2 | $52.4M | Sell |
291,886
-15,983
| -5% | -$2.78M | 0.06% | 411 |
|
|
2025
Q1 | $52.1M | Sell |
307,869
-50,241
| -14% | -$8.25M | 0.06% | 399 |
|
|
2024
Q4 | $53.4M | Sell |
358,110
-1,431
| -0.4% | -$223K | 0.06% | 400 |
|
|
2024
Q3 | $55.8M | Sell |
359,541
-22,908
| -6% | -$3.42M | 0.06% | 420 |
|
|
2024
Q2 | $52.3M | Sell |
382,449
-32,440
| -8% | -$4.44M | 0.06% | 405 |
|
|
2024
Q1 | $55.2M | Buy |
414,889
+9,107
| +2% | +$1.18M | 0.06% | 402 |
|
|
2023
Q4 | $55.9M | Sell |
405,782
-17,427
| -4% | -$2.29M | 0.06% | 402 |
|
|
2023
Q3 | $51.6M | Sell |
423,209
-5,318
| -1% | -$709K | 0.06% | 400 |
|
|
2023
Q2 | $60.2M | Buy |
428,527
+255,608
| +148% | +$35.2M | 0.07% | 368 |
|
|
2023
Q1 | $24.5M | Sell |
172,919
-17,701
| -9% | -$2.53M | 0.03% | 615 |
|
|
2022
Q4 | $29.8M | Sell |
190,620
-3,282
| -2% | -$472K | 0.04% | 607 |
|
|
2022
Q3 | $23.8M | Buy |
193,902
+1,098
| +0.6% | +$145K | 0.03% | 647 |
|
|
2022
Q2 | $25.6M | Sell |
192,804
-662
| -0.3% | -$90.2K | 0.03% | 649 |
|
|
2022
Q1 | $26.5K | Sell |
193,466
-393,357
| -67% | -$54.8M | 0.02% | 699 |
|
|
2021
Q4 | $102M | Sell |
586,823
-29,435
| -5% | -$4.48M | 0.08% | 301 |
|
|
2021
Q3 | $89.5M | Buy |
616,258
+10,484
| +2% | +$1.53M | 0.08% | 336 |
|
|
2021
Q2 | $79.9M | Buy |
605,774
+378,585
| +167% | +$49.6M | 0.07% | 377 |
|
|
2021
Q1 | $29.2M | Sell |
227,189
-4,464
| -2% | -$550K | 0.04% | 446 |
|
|
2020
Q4 | $27.6M | Sell |
231,653
-11,766
| -5% | -$1.43M | 0.04% | 442 |
|
|
2020
Q3 | $27.9M | Sell |
243,419
-12,766
| -5% | -$1.51M | 0.05% | 386 |
|
|
2020
Q2 | $29.2M | Sell |
256,185
-178
| -0.1% | -$18.9K | 0.05% | 381 |
|
|
2020
Q1 | $20.6M | Buy |
256,363
+2,644
| +1% | +$274K | 0.04% | 408 |
|
|
2019
Q4 | $27.1M | Buy |
253,719
+122,245
| +93% | +$12.7M | 0.04% | 431 |
|
|
2019
Q3 | $14.1M | Sell |
131,474
-7,817,068
| -98% | -$802M | 0.02% | 530 |
|
|
2019
Q2 | $809M | Sell |
7,948,542
-120,335
| -1% | -$11.6M | 1.36% | 13 |
|
|
2019
Q1 | $726M | Buy |
8,068,877
+360,327
| +5% | +$31.2M | 1.24% | 22 |
|
|
2018
Q4 | $642M | Buy |
7,708,550
+1,000,318
| +15% | +$93.8M | 1.24% | 23 |
|
|
2018
Q3 | $724M | Buy |
6,708,232
+306,017
| +5% | +$33.6M | 1.18% | 26 |
|
|
2018
Q2 | $704M | Sell |
6,402,215
-413,466
| -6% | -$43.1M | 1.21% | 18 |
|
|
2018
Q1 | $684M | Sell |
6,815,681
-42,588
| -0.6% | -$4.36M | 1.25% | 18 |
|
|
2017
Q4 | $675M | Sell |
6,858,269
-19,657
| -0.3% | -$1.86M | 1.19% | 27 |
|
|
2017
Q3 | $644M | Sell |
6,877,926
-410,955
| -6% | -$43.6M | 1.16% | 33 |
|
|
2017
Q2 | $810M | Sell |
7,288,881
-1,075,030
| -13% | -$114M | 1.48% | 5 |
|
|
2017
Q1 | $821M | Sell |
8,363,911
-231,125
| -3% | -$22M | 1.49% | 7 |
|
|
2016
Q4 | $790M | Sell |
8,595,036
-334,536
| -4% | -$28.8M | 1.51% | 11 |
|
|
2016
Q3 | $756M | Sell |
8,929,572
-9,969,238
| -53% | -$837M | 1.45% | 9 |
|
|
2016
Q2 | $1.54B | Buy |
18,898,810
+9,002,169
| +91% | +$685M | 1.5% | 7 |
|
|
2016
Q1 | $707M | Buy |
9,896,641
+550,992
| +6% | +$37M | 1.42% | 8 |
|
|
2015
Q4 | $665M | Buy |
9,345,649
+360,993
| +4% | +$24.3M | 1.37% | 6 |
|
|
2015
Q3 | $552M | Buy |
8,984,656
+353,506
| +4% | +$24.7M | 1.18% | 27 |
|
|
2015
Q2 | $626M | Buy |
8,631,150
+308,161
| +4% | +$22.8M | 1.24% | 8 |
|
|
2015
Q1 | $640M | Sell |
8,322,989
-92,826
| -1% | -$6.65M | 1.26% | 5 |
|
|
2014
Q4 | $564M | Buy |
8,415,815
+379,219
| +5% | +$23.9M | 1.16% | 9 |
|
|
2014
Q3 | $488M | Buy |
8,036,596
+434,476
| +6% | +$26.8M | 1.05% | 24 |
|
|
2014
Q2 | $446M | Buy |
7,602,120
+29,865
| +0.4% | +$1.75M | 1% | 18 |
|
|
2014
Q1 | $439M | Buy |
7,572,255
+582,909
| +8% | +$31.2M | 0.76% | 37 |
|
|
2013
Q4 | $374M | Buy |
6,989,346
+1,296,875
| +23% | +$76.9M | 0.67% | 61 |
|
|
2013
Q3 | $352M | Buy |
5,692,471
+528,972
| +10% | +$31.7M | 0.69% | 48 |
|
|
2013
Q2 | $313M | Buy |
+5,163,499
| New | +$308M | 0.68% | 49 |
|
Other funds holding DGX
VCM
VPM
EIG
Macquarie Group's DGX Position: Q1 2026 in Review
Macquarie Group reduced its Quest Diagnostics (DGX) stake by 9.7% in Q1 2026, selling an estimated $295K and leaving 14,170 shares worth $2.77M. The position accounts for 0.02% of the portfolio, ranked #470.
Macquarie Group first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54B in Q2 2016. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Macquarie Group held 14,170 shares of Quest Diagnostics worth $2.77M as of Q1 2026.
- Macquarie Group sold 1,517 Quest Diagnostics shares in Q1 2026, an estimated $295K.
- Quest Diagnostics made up 0.02% of Macquarie Group's portfolio in Q1 2026, its #470 holding.
- Macquarie Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's Quest Diagnostics position peaked at $1.54B in Q2 2016.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.